Bill Gates's position in Regeneron Pharmaceuticals is currently worth $18.7 Million. That's 0.04% of their equity portfolio (22nd largest holding). Bill Gates acquired their 35.5 Thousand shares in Q1 2009. So far they never sold any shares in the company. The stake costed the investor $576 Thousand, netting the investor a gain of 3154% so far.